🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jijun Wang

Tianjin University

ORCID: 0000-0001-5427-7425

Also affiliated with Shanghai Jiao Tong University, Nantong University, Shanghai Mental Health Center, Center for Excellence in Brain Science and Intelligence Technology, Tianjin Anding Hospital, Nantong Tumor Hospital, Second People's Hospital of NanTong, Institute of Psychology, Chinese Academy of Sciences

MedicineNeuroscienceArts and Humanities

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.533Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00561-w
Top 63%
0.215DataRank
Top 63%3 citations

Pablo Polosecki, Jean Addington, Celso Arango, Ameneh Asgari-Targhi, Tashrif Billah +58 more

Papers

Driven by 16 papers — median percentile 37. Top paper: “Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis”.

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

Schizophrenia Bulletin(2024)10.1093/schbul/sbae011
N/A
0.984DataRank · unranked
78 citations

Barnaby Nelson, Jean Addington, Kelly Allott, Alan Anticevic, Celso Arango +95 more

Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00599-w
N/A
0.373DataRank · unranked
11 citations

Ann Ee Ching, Yoonho Chung, Habiballah Rahimi-Eichi, Erlend Lane, Carsten Langholm +75 more

The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

Schizophrenia(2025)10.1038/s41537-025-00622-0
N/A
0.333DataRank · unranked
8 citations

Spero Nicholas, Brian J. Roach, Tashrif Billah, Suzie Lavoie, Thomas J. Whitford +95 more

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00581-6
N/A
0.330DataRank · unranked
8 citations

Kang Ik K. Cho, Alan Anticevic, Nicolas R. Bolo, Sylvain Bouix, Dylan Campbell +82 more

Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

Schizophrenia(2025)10.1038/s41537-025-00578-1
N/A
0.330DataRank · unranked
8 citations

Walid Yassin, Luis Alameda, Tashrif Billah, Owen Borders, Kate Buccilli +93 more

Magnetic seizure therapy for treatment-resistant depression

Cochrane Database of Systematic Reviews(2020)10.1002/14651858.cd013528
N/A
0.269DataRank · unranked
5 citations

Chunbo Li, Zhimin Chen, Xinyi Cao, Hongyan Wang, Wei Li +2 more

Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative

Schizophrenia(2025)10.1038/s41537-025-00669-z
N/A
0.269DataRank · unranked
5 citations

Eduardo Castro, Carla Agurto, Einat Liebenthal, Michaela Ennis, Justin T. Baker +72 more

Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program

Schizophrenia(2025)10.1038/s41537-025-00561-w
Top 63%
0.215DataRank
Top 63%3 citations

Pablo Polosecki, Jean Addington, Celso Arango, Ameneh Asgari-Targhi, Tashrif Billah +58 more

Two neurostructural subtypes: results of machine learning on brain images from 4,291 individuals with schizophrenia

medRxiv(2023)10.1101/2023.10.11.23296862
Top 63%
0.214DataRank
Top 63%3 citations

Cheng Luo, Jijun Wang, Lena Palaniyappan, Xiao Chang, Shitong Xiang +95 more

Microstructural Cortical Gray Matter Changes Preceding Accelerated Volume Changes in Individuals at Clinical High Risk for Psychosis

Research Square(2023)10.21203/rs.3.rs-3179575/v1
N/A
0.104DataRank · unranked
1 citations

Ofer Pasternak, Fan Zhang, Nora Penzel, Johanna Seitz‐Holland, Yingying Tang +10 more

Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program

Schizophrenia Bulletin Open(2025)10.1093/schizbullopen/sgaf013
Top 78%
0.104DataRank
Top 78%1 citations

Amy Shalev, Lu Liu, Cari Jahraus, Monica Chu, Emily K. Farina +75 more

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

UNC Libraries(2024)10.17615/rqtf-zj40
N/A
0DataRank · unranked
0 citations

Kerstin Langbein, Andrew Thompson, Louise Birkedal Glenthøj, César Salinas, Patrick D. McGorry +95 more

Editorial: Identifying Individuals at Clinical High Risk of Psychosis in Different Cultures and Countries

Frontiers in Psychiatry(2020)10.3389/fpsyt.2020.00159
N/A
0DataRank · unranked
1 citations

Jijun Wang, Kristen A. Woodberry, Tianhong Zhang

Neuroimaging biomarkers define neurophysiological subtypes with distinct trajectories in schizophrenia

Nature Mental Health(2023)10.1038/s44220-023-00024-0
N/A
0DataRank · unranked
96 citations

Jijun Wang, Enpeng Zhou, Lena Palaniyappan, Cheng Luo, Gong‐Jun Ji +35 more

Dopaminergic-related Anatomical Pattern of Dorsal Striatum in Schizophrenia

medRxiv(2023)10.1101/2023.11.30.23298956
N/A
0DataRank · unranked
0 citations

Shitong Xiang, Yueyuan Zheng, Chun Shen, Xue-Rui Peng, Yuzhu Li +22 more

MK-Curve improves sensitivity to identify white matter alterations in clinical high risk for psychosis

NeuroImage(2020)10.1016/j.neuroimage.2020.117564
N/A
0DataRank · unranked
17 citations

Kang Ik Kevin Cho, Yingying Tang, Tianhong Zhang, Sinéad Kelly, Maria A. Di Biase +10 more